KeyCorp Cuts HealthEquity (NASDAQ:HQY) Price Target to $110.00

HealthEquity (NASDAQ:HQY) had its target price lowered by KeyCorp from $120.00 to $110.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other equities research analysts also recently commented on the stock. Raymond James boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Finally, Royal Bank of Canada increased their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $113.31.

HealthEquity Trading Down 1.1 %

HQY stock opened at $89.22 on Monday. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $104.17 and its 200-day moving average is $95.89. The firm has a market cap of $7.72 billion, a P/E ratio of 81.85, a P/E/G ratio of 1.60 and a beta of 0.62.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently made changes to their positions in the stock. Wealthfront Advisers LLC bought a new position in HealthEquity during the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. raised its holdings in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock worth $861,256,000 after purchasing an additional 99,624 shares during the period. Wasatch Advisors LP boosted its position in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares in the last quarter. FMR LLC grew its holdings in shares of HealthEquity by 2.4% in the 4th quarter. FMR LLC now owns 5,415,800 shares of the company’s stock valued at $519,646,000 after buying an additional 125,684 shares during the period. Finally, State Street Corp grew its holdings in shares of HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after buying an additional 23,613 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.